No Settlement

U.S. prosecutors had been negotiating a dispute settlement that may cost Ranbaxy more than $1 billion, Fortune magazine reported in May, without saying where it got the information. There was no mention of a settlement in the FDA’s statement yesterday.Making generic Lipitor in the U.S. instead of India will reduce the amount of profit Ranbaxy makes on each dollar of sales, Kotak’s Arora said.“Margins for manufacturing in the India are around 60 percent compared to about 40 percent from the U.S.,” she said. Cheap Ugg Boots The brokerage had estimated Ranbaxy would generate $560 million in generic-Lipitor sales during the six months of exclusivity.“We will have to revise our estimates because of this and the Teva deal,” Arora said.